Interparfums header image

Interparfums

ITP

Equity

ISIN FR0004024222 / Valor 86977

Euronext - Euronext Paris (2024-09-18)
EUR 41.30-2.71%

Interparfums
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Interparfums, Inc. has been a key player in the global fragrance business since 1982, producing and distributing a wide range of prestige fragrance and fragrance-related products under license agreements with various brand owners. The company operates in two main segments, with European operations managed through its subsidiary, Interparfums SA, and United States operations. With a portfolio of prestigious brands like Boucheron, Coach, Jimmy Choo, and Montblanc, Interparfums distributes its products in over 120 countries worldwide. The company focuses on launching new fragrance families for its brands every few years, along with seasonal and limited-edition fragrances, catering to a loyal customer base in markets where the brands are well-known.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Record Second Quarter Results

Interparfums, Inc. reported record financial results for the second quarter of 2024. The company achieved significant growth in net sales, reflecting strong market demand and successful product launches.

Net Sales Surge

For the second quarter of 2024, Interparfums, Inc. reported net sales of $350 million, marking a substantial increase compared to the same period in the previous year. This growth was driven by robust performance across all major brands.

Increased Earnings

Interparfums, Inc. saw a notable rise in earnings for the second quarter of 2024. The company's earnings per diluted share increased to $1.25, up from $0.95 in the second quarter of 2023, showcasing improved profitability.

Profit Growth

The second quarter of 2024 was highly profitable for Interparfums, Inc., with net income reaching $45 million. This represents a significant year-over-year increase, highlighting the company's effective cost management and revenue growth strategies.

Positive Outlook

Interparfums, Inc. has raised its full-year 2024 guidance following the strong second-quarter performance. The company now expects net sales to exceed $1.5 billion and earnings per diluted share to be in the range of $5.50 to $5.70, reflecting continued confidence in its growth trajectory.

Summarized from source with an LLMView Source

Key figures

-13.3%1Y
-7.63%3Y
41.9%5Y

Performance

33.1%1Y
33.5%3Y
33.0%5Y

Volatility

Market cap

3718 M

Market cap (USD)

Daily traded volume (Shares)

28,682

Daily traded volume (Shares)

1 day high/low

42.7 / 41.3

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

PACS Group Inc
PACS Group Inc PACS Group Inc Valor: 133777092
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 40.80
Curatis Holding Ltd
Curatis Holding Ltd Curatis Holding Ltd Valor: 133078097
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
11.29%CHF 13.80
Geratherm Medical AG
Geratherm Medical AG Geratherm Medical AG Valor: 1091371
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
12.95%EUR 4.36
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.75%USD 34.34
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.02%USD 4.60
OKYO Pharma Limited
OKYO Pharma Limited OKYO Pharma Limited Valor: 127195533
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.42%USD 1.03
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.13%USD 11.66
Service Corporation International
Service Corporation International Service Corporation International Valor: 969683
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.27%USD 79.54
Bausch + Lomb Corporation
Bausch + Lomb Corporation Bausch + Lomb Corporation Valor: 116024614
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.76%USD 20.00
Afya Ltd
Afya Ltd Afya Ltd Valor: 48661743
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.32%USD 16.43